Oxford Immunotec

Fifty million screening tests are performed for tuberculosis each year, but Oxford Immunotec claims that the established diagnosis method is inefficient and unreliable. It says its lead product T-SPOT saves time and is more accurate. This University of Oxford spin-out was co-founded by Dr Peter Wrighton-Smith and Professor Ajit Lalvani in 2002, and sales increased 59% a year from £2m in 2008 to £8m in 2011. In June, Imperial Innovations and Invesco Perpetual led an £18.2m funding round, which will be used for global marketing.

This profile reflects the company at time of publication and does not reflect any changes that may have subsequently occurred. Fast Track and its sponsors do not endorse, guarantee or recommend investment in any of the companies.

Company details
Year2012
Rank52
CompanyOxford Immunotec
ActivityMedical diagnostics provider
LocationAbingdon
Average 3 year sales growth58.52%
Latest sales £000s7,970
Staff97
Founded2002
Websitewww.oxfordimmunotec.com

If applicable:

* supplied by company † annualised figure